Verastem Oncology Publishes Phase 2 RAMP 201 Results: Avutometinib + Defactinib in Recurrent LGSOC Verastem Oncology, focused on therapies for RAS/MAPK pathway-driven cancers, today announced the primary outcomes of the Phase 2 RAMP 201 trial have been published online in JCO.…
Elegen and Nutcracker Therapeutics Launch Cell‑Free Platform for Personalized Cancer RNA Therapies Pilot program introduces the first fully synthetic, cell‑free process to streamline manufacturing of RNA-based personalized cancer therapeutics (PCTs) Elegen, a pioneer in next‑generation DNA manufacturing, and Nutcracker Therapeutics,…
IDT Unveils Advanced Synthetic Biology Center and Gene Fragment Services Faster, Affordable, and Tailored DNA Solutions for Researchers Global genomics leader Integrated DNA Technologies (IDT) has officially launched a state-of-the-art Synthetic Biology Center dedicated to custom gene solutions. This expansion…
Comprehensive Training on GLP Compliance Documentation and Recordkeeping Now Available ResearchAndMarkets.com has recently introduced a new online seminar titled “GLP Laboratory Compliance Documentation and Recordkeeping” designed to equip laboratory professionals with the essential knowledge and skills needed to maintain rigorous…
New Research Uncovers Powerful Health-Promoting Compounds in California Almonds New Research Uncovers Powerful Health-Promoting Compounds in California Almonds California almonds—already known for their heart-healthy and nutrient-rich profile—may be even more beneficial than previously thought. Brightseed, a pioneering company in nutritional…
FeedKind® Pet Protein Proven Safe, Digestible, and Gut-Friendly in Long-Term Study Calysta’s cultured protein shows strong results in peer-reviewed research, paving the way for sustainable innovation in pet food the global leader in large-scale cultured protein production, has announced peer-reviewed…
Broken String Biosciences and BioLizard Join Forces to Build AI Platform for Safer Gene Editing New SafeGuide AI tool aims to reduce trial-and-error in gene editing and lower development costs for next-generation therapies Broken String Biosciences, a pioneer in genomic…
TandemAI and Perpetual Medicines Merge to Advance AI and Physics-Driven Drug Discovery Newly combined company will broaden capabilities in small molecule and peptide therapeutics with expanded leadership and integrated technology platforms In a strategic move that strengthens innovation at the…
Renasant Bio Launches with $54.5M to Advance Next-Generation Therapies for ADPKD Renasant Bio (Renasant) today announced its official launch with a bold mission: to pioneer next-generation, disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD)—the most common inherited cause of…
Feinstein Institutes Study Focused Ultrasound to Regulate Blood Sugar After Surgery Researchers and clinicians at Northwell Health’s Feinstein Institutes for Medical Research are breaking new ground in the field of bioelectronic medicine, exploring the use of focused ultrasound (FUS) to…
NTT and Tohoku University Pioneer Quantum Leap with Single-Photon Coherent Ising Machines NTT Research and Tohoku University have jointly achieved a significant scientific milestone, pushing the boundaries of quantum computing by developing a highly energy-efficient and powerful form of Coherent…
European Students Excel in Global Cambridge Science Competition Three student teams from across Europe have been honored with awards in the prestigious 2025 Cambridge Science Competition, an international initiative hosted by the International Education division at Cambridge University Press &…